Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Opioid Use Disorder · Opioid Use Disorder, Moderate · Opioid Use Disorder, Severe

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Gateway Community Services, Jacksonville, Florida, United States
Contact: Study coordinator (Candace Hodgkins, PhD.) · chodgkins@gwjax.com · 904-387-4661
Contact: Study coordinator (Joseph Seim) · jseim@gwjax.com · 904-387-4661
IBIS Behavioral Health, Tampa, Florida, United States
Contact: Study coordinator (Alexander Sinu, MD) · asinu@ibishc.org · 813-384-4000
Ruth M. Rothstein CORE Center, Chicago, Illinois, United States
Contact: Study coordinator (Pamela Vergara-Rodriguez, MD) · pamela.vergara@cookcountyhhs.org · 312-572-4753
Contact: Study coordinator (Mireya Gonzalez) · mireya.gonzalez@cookcountyhealth.org · 312-572-4555
The Gibson Center for Behavioral Change, Cape Girardeau, Missouri, United States
Contact: Study coordinator (Ashley Naeger) · naegera@gibsonrecovery.org · 573-803-4158
Prisma Health, Greenville, South Carolina, United States
Contact: Study coordinator (Alain Litwin, MD) · alain.litwin@prismahealth.org · 864-430-0911
Contact: Study coordinator (Anthony Faso) · anthony.faso@prismahealth.org · 864-455-1584
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Jessica L Young, MD) · jessica.l.young@vumc.org · 615-585-9889
Contact: Study coordinator (Stephanie Hartwig) · stephanie.m.hartwig@vumc.org · 615-875-0578
University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Marcela Smid, MD, MS, MA) · tab@utah.edu · 385-977-2445
Contact: Study coordinator (Kathryn Szczotka) · tab@utah.edu · 385-977-2445
Marshall Health, Huntington, West Virginia, United States
Contact: Study coordinator (Zachary Hansen, MD) · hansen8@marshall.edu · 304-696-8700
Contact: Study coordinator (Lacey Andrews) · andrews29@marshall.edu · 304-691-6404
Healthy Minds/Chestnut Ridge, Morgantown, West Virginia, United States
Contact: Study coordinator (Laura Lander, MSW, LICSW) · llander@hsc.wvu.edu · 304-293-3965
Contact: Study coordinator (Michelle Chisester) · michelle.chidester@hsc.wvu.edu

Study leads

T. John Winhusen, PhD.
Principal Investigator
University of Cincinnati

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Brenipatide in Participants With Opioid Use Disorder

Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Little Rock, United States

Evaluating Buspirone to Treat Opioid Withdrawal

Opioid Use Disorder · Opioid Withdrawal · Opioid Craving

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use

Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2

Philadelphia, United States

Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery

Pain, Postoperative · Ankle Fracture Surgery · Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE4

St Louis, United States